Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension.

Pharmacogenomics - 1 Apr 2006

Bremer Troy, Man Albert, Kask Kalev, Diamond Cornelius

Abstract excerpt

Retrospective pharmacogenetic analysis was performed on 120 Caucasian subjects. Subjects were obtained in collaboration with the Estonian Genome Project and Egeen Inc. (CA, USA), who provided blinded medical record and genetic data to the researchers, respectively. Subjects selected from the Estonian Genome Project had a diagnosis of hypertension confirmed by at least two blood pressure measurements and multiple...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged, 80 and over
Share to Antihypertensive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Calcium Channel Blockers

Share to Calcium Channels, L-Type

Share to Haplotypes

Share to Hypertension

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 16610939
DOI: 10.2217/14622416.7.3.271

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension.PMID 16610939Read ↗

[Impact of CACNA1C polymorphisms on antihypertensive efficacy of calcium channel blocker].Semantic proximity Read ↗

CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response.Semantic proximity Read ↗

Genetic polymorphisms of L-type calcium channel alpha1C and alpha1D subunit genes are associated with sensitivity to the antihypertensive effects of L-type dihydropyridine calcium-channel blockers.Semantic proximity Read ↗

Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.Semantic proximity Read ↗

Calcium Channel Blockers: clinical outcome associations with reported pharmacogenetics variants in 32,000 patientsSemantic proximity Read ↗

CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiologySemantic proximity Read ↗

Associations of Variants in the CACNA1A and CACNA1C Genes With Longitudinal Blood Pressure Changes and Hypertension Incidence: The GenSalt Study.Semantic proximity Read ↗

Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes.Semantic proximity Read ↗

L-type voltage-dependent calcium channel alpha subunit 1C is a novel candidate gene associated with secondary hyperparathyroidism: an application of haplotype-based analysis for multiple linked single nucleotide polymorphisms.Semantic proximity Read ↗

Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES).Semantic proximity Read ↗

Single-nucleotide polymorphisms in vascular Ca2+-activated K+-channel genes and cardiovascular disease.Semantic proximity Read ↗

CACNA1H Calcium Channel Mutations in Primary Aldosteronism - Is Sodium the Culprit?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.